Filter
980
Filtered Results: 980
Text search:
pharmaceutical
procurement
Featured
Recommendations
106
New Publications
308
Language
Document type
No document type
508
Studies & Reports
178
Guidelines
149
Strategic & Response Plan
59
Manuals
44
Fact sheets
18
Training Material
10
Situation Updates
9
Resource Platforms
3
Brochures
1
Infographics
1
Countries / Regions
Ethiopia
57
Kenya
51
Global
34
India
33
Uganda
28
Sierra Leone
25
South Africa
25
Nigeria
23
Liberia
23
Ghana
19
Malawi
19
Tanzania
19
Nepal
17
Rwanda
17
Western and Central Europe
16
Zambia
16
Bangladesh
14
Ukraine
13
Namibia
13
Zimbabwe
12
Philippines
12
Africa
12
Lesotho
11
Eastern Europe
9
Syria
8
Cambodia
8
Senegal
7
Latin America and the Carribbean
7
Congo, Democratic Republic of
7
Myanmar / Burma
7
Botswana
6
Indonesia
6
Eswatini/ Swaziland
6
Benin
5
Cameroon
5
Burkina Faso
5
Asia
5
West and Central Africa
5
South–East Asia Region
5
East and Southern Africa
5
Haiti
4
Guinea
3
Mozambique
3
Middle East and North Africa
3
North America
3
Papua New Guinea
3
Sudan
3
Thailand
2
Albania
2
Jordan
2
Western Pacific Region
2
Lebanon
2
Yemen
2
South Sudan
2
Pakistan
2
North Macedonia
1
Tajikistan
1
Timor Leste/ East Timor
1
Fiji
1
Laos
1
Germany
1
Saudi Arabia
1
Eastern Europe and Central Asia
1
Paraguay
1
Gabon
1
Maldives
1
Southern Africa
1
Brazil
1
Moldova
1
Russia
1
Central African Republic
1
Mali
1
Libya
1
Somalia
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
493
Clinical Guidelines
57
Public Health
40
Key Resources
34
Pharmacy & Technologies
23
Women & Child Health
22
Capacity Building
5
Annual Report MEDBOX
1
Toolboxes
Pharmacy
109
AMR
94
COVID-19
65
HIV
58
TB
52
Rapid Response
26
Planetary Health
20
NTDs
19
Health Financing Toolbox
19
Conflict
16
NCDs
15
Global Health Education
13
Mental Health
12
Ebola
11
Caregiver
9
Natural Hazards
4
Polio
3
Refugee
2
Disability
2
Cholera
2
Health Financing
2
Specific Hazards
1
Zika
1
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
I examine the effectiveness of donors in targeting the highest burden of malaria in the Democratic Republic of Congo when health information structure is fragmented. I exploit local variations in the burden of malaria induced by mining activities as well as financial and epidemiological data from he...
The development of this draft Proposed programme budget 2022–2023 comes at a unique moment for WHO. The world is in the grip of the coronavirus disease (COVID-19) pandemic and faces health, social and economic consequences on an unprecedented scale. Although it is not known when the COVID-19 pande...
The thirty-seventh meeting of the Programme, Budget and Administration Committee was held in Geneva from 25 to 27 January 2023 and chaired by Ms Aishath Rishmee (Maldives). The Committee adopted its agenda and agreed its programme of work. In his opening remarks, the Director-General emphasized the ...
This report examines the support to private healthcare provision in India by the World Bank’s private sector arm, the International Finance Corporation (IFC). Despite supporting private healthcare in the country since 1997, no healthcare results for lending and investments have been disclosed sinc...
The burden of diabetes is enormous, positioning it as one of the main challenges facing public health today. Currently, it is estimated that 62 million people are living with diabetes in the Region of the Americas and projections show its prevalence will continue rising over the following years. The...
La carga de la diabetes es enorme, posicionándola como uno de los principales desafíos que enfrenta la salud pública en la actualidad. Actualmente, se estima que 62 millones de personas viven con diabetes en la Región de las Américas y las proyecciones muestran que su prevalencia seguirá aumen...
Trustworthy, evidence-based health guidelines form the basis of national policies affecting both patients and health-care workers. Emphasizing the link between robust evidence and people’s trust in their health systems, Dr Hans Henri P. Kluge, WHO Regional Director for Europe said at the launch ev...
In an ambitious new era for health development under the 2030 Agenda for Sustainable Development, WHO and
its partners have a solid foundation of success on which to build. Health plays a fundamental role in development
and is the central focus of Sustainable Development Goal 3, “Ensure healthy ...
WHO today released its first roadmap to tackle postpartum haemorrhage (PPH) – defined as excessive bleeding after childbirth - which affects millions of women annually and is the world’s leading cause of maternal deaths.
Despite being preventable and treatable, PPH results in around 70 000 de...
This document lays out economic arguments for investing in the Access to COVID-19 Tools Accelerator (ACT-Accelerator). Framed within an overall context that recognizes the broader human health and societal impacts of the COVID-19 crisis, ACT-Accelerator's Economic Investment Case argues that investm...
This article analyzes the impact of the COVID-19 pandemic on foreign aid. Using examples from Canadian foreign aid, it argues that, despite the terrible toll it is exacting, the crisis has accelerated some significant positive pre-existing trends, both by destabilizing the perception of aid as flowi...
Background: Cardiovascular disease (CVD), mainly heart attack and stroke, is the
leading cause of premature mortality in low and middle income countries (LMICs).
Identifying and managing individuals at high risk of CVD is an important strategy to prevent and control CVD, in addition to multisector...
